61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Sanofi SA
Closed
Sector Healthcare
104.38 0.31
Overview
Share price change
24h
Min
103.58
Max
104.76
Income | 1.7B 2.8B |
|---|---|
Sales | -2.9B 11B |
P/E Sector Avg | 30.62 59.362 |
EPS | 1.31 |
Dividend yield | 4.011 |
Profit margin | 20.945 |
EBITDA | 2.2B 4.2B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +9.02 upside |
Dividend yield Sector Avg | 4.01% 2.35% |
|---|---|
Next Earnings | 24 Apr 2025 |
Market Cap | 131B |
|---|---|
Previous open | 104.07 |
Previous close | 104.38 |
News Sentiment
By Acuity
49%
51%
141 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Sanofi SA Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Sanofi SA Forecast
Price Target
By TipRanks
9.02% upside
12 Months Forecast
Average 113.819 EUR 9.02%
High 125 EUR
Low 92 EUR
Based on 12 Wall Street analysts offering 12 month price targets forSanofi SA - Dist in the last 3 months.
Sentiment
By Acuity
141 / 393 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Sanofi SA
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.
